Search alternatives:
shape decrease » shape increases (Expand Search), small decrease (Expand Search), showed decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), showed decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1401
The heart rate was similar among the groups.
Published 2025“…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…”
-
1402
S1 File -
Published 2025“…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…”
-
1403
Primer sequences for RT-qPCR.
Published 2025“…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…”
-
1404
-
1405
-
1406
-
1407
-
1408
-
1409
-
1410
-
1411
-
1412
-
1413
-
1414
-
1415
Changes in health-related quality of life indexes before and after disease onset.
Published 2025Subjects: -
1416
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
1417
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
1418
-
1419
-
1420